Lonza Group AG

Lonza Group AG, headquartered in Basel, delivers end‑to‑end biopharma, small‑molecule, cell & gene therapy, and nutraceutical manufacturing across 5 regions, driving growth through advanced contract services, Cocoon platform, and global collaborations.

Headquarters: Switzerland (CHE)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Manufacturing
Industry: Pharmaceutical Manufacturing

Employees: 19,299
HQ: Basel

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
LONN	Lonza Group AG Cap: 39.0B \| P/E: 53.5	EQUITY	EBS	CHF	CH0013841017	Active	📈